Halpern, Zamir

Personalized nutrition by prediction of glycemic responses

Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell

Nutrition, Genetics, and DiseaseDiabetes Management and Research

Cited by 2,929

Environment dominates over host genetics in shaping human gut microbiota

Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., Costea, P. I., Godneva, A., Kalka, I. N., Bar, N., et al. (2018) · Nature

Gut microbiota and healthGenetic Associations and Epidemiology

Cited by 2,859

Artificial sweeteners induce glucose intolerance by altering the gut microbiota

Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. (2014) · Nature

Gut microbiota and healthBiochemical Analysis and Sensing Techniques

Cited by 2,067

Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features

Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., Kotler, E., Zur, M., Regev-Lehavi, D., Brik, R. B.-Z., et al. (2018) · Cell

Probiotics and Fermented FoodsGut microbiota and health

Cited by 1,695

Transkingdom Control of Microbiota Diurnal Oscillations Promotes Metabolic Homeostasis

Thaiss, C. A., Zeevi, D., Levy, M., Zilberman-Schapira, G., Suez, J., Tengeler, A. C., Abramson, L., Katz, M. N., Korem, T., Zmora, N., et al. (2014) · Cell

Gut microbiota and healthCircadian rhythm and melatonin

Cited by 1,449

Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT

Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Ben-Zeev Brik, R., Federici, S., et al. (2018) · Cell

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 1,184

Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling

Levy, M., Thaiss, C. A., Zeevi, D., Dohnalová, L., Zilberman-Schapira, G., Mahdi, J. A., David, E., Savidor, A., Korem, T., Herzig, Y., et al. (2015) · Cell

Gut microbiota and healthInflammasome and immune disorders

Cited by 960

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection

Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., et al. (2018) · Science

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 942

Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations

Thaiss, C. A., Levy, M., Korem, T., Dohnalová, L., Shapiro, H., Jaitin, D. A., David, E., Winter, D. R., Gury-BenAri, M., Tatirovsky, E., et al. (2016) · Cell

Gut microbiota and healthCircadian rhythm and melatonin

Cited by 870

Persistent microbiome alterations modulate the rate of post-dieting weight regain

Thaiss, C. A., Itav, S., Rothschild, D., Meijer, M. T., Levy, M., Moresi, C., Dohnalová, L., Braverman, S., Rozin, S., Malitsky, S., et al. (2016) · Nature

Gut microbiota and healthRegulation of Appetite and Obesity

Cited by 471

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase

Ben-Shlomo, S., Zvibel, I., Shnell, M., Shlomai, A., Chepurko, E., Halpern, Z., Barzilai, N., Oren, R., & Fishman, S. (2011) · Journal of Hepatology

Metabolism, Diabetes, and CancerDiabetes Treatment and Management

Cited by 328

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

Zelber–Sagi, S., Kessler, A., Brazowsky, E., Webb, M., Lurie, Y., Santo, M., Leshno, M., Blendis, L., Halpern, Z., & Oren, R. (2006) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentPharmacology and Obesity Treatment

Cited by 317

Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study

Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Zvibel, I., Goldiner, I., Blendis, L., Halpern, Z., & Oren, R. (2008) · Hepatology

Liver Disease Diagnosis and TreatmentPhysical Activity and Health

Cited by 296

Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel disease

Valdés-Mas, R., Leshem, A., Zheng, D., Cohen, Y., Kern, L., Zmora, N., He, Y., Katina, C., Eliyahu-Miller, S., Yosef-Hevroni, T., et al. (2025) · Cell

Gut microbiota and healthInflammatory Bowel Disease

Cited by 89

Long-Acting Glucose-Dependent Insulinotropic Polypeptide Ameliorates Obesity-Induced Adipose Tissue Inflammation

Varol, C., Zvibel, I., Spektor, L., Mantelmacher, F. D., Vugman, M., Thurm, T., Khatib, M., Elmaliah, E., Halpern, Z., & Fishman, S. (2014) · The Journal of Immunology

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 89

Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome: Hs-CRP in irritable bowel syndrome

Hod, K., Dickman, R., Sperber, A., Melamed, S., Dekel, R., Ron, Y., Halpern, Z., Berliner, S., & Maharshak, N. (2011) · Neurogastroenterology & Motility

Gastrointestinal motility and disordersGut microbiota and health

Cited by 36